Expressions of matrix metalloproteinases in inflammatory bowel diseases

Crohn's disease (CD) and ulcerative colitis (UC) belong to a group of inflammatory bowel diseases (IBD). The aim of our study was to evaluate the expression of MMP-2, MMP-7, MMP-9, TIMP-1, and TIMP-2 in ulcerative colitis and Crohn's disease. The study group comprised 34 patients with UC a...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterology research and practice 2016-01
Main Authors: Jakubowska, Katarzyna, Pryczynicz, Anna, Iwanowicz, Piotr, Niewinski, Andrzej, Maciorkowska, Elzbieta, Hapanowicz, Jerzy, Jagodzinska, Dorota, Kemona, Andrzej, Guzinska-Ustymowicz, Katarzyna
Format: Article
Language:English
Subjects:
Care and treatment
Development and progression
Gene expression
Genetic aspects
Health aspects
Inflammatory bowel diseases
Proteases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Crohn's disease (CD) and ulcerative colitis (UC) belong to a group of inflammatory bowel diseases (IBD). The aim of our study was to evaluate the expression of MMP-2, MMP-7, MMP-9, TIMP-1, and TIMP-2 in ulcerative colitis and Crohn's disease. The study group comprised 34 patients with UC and 10 patients with CD. Evaluation of MMP-2, MMP-7, MMP-9, TIMP-1, and TIMP-2 expression in tissue samples was performed using immunohistochemistry. The overexpression of MMP-9 and TIMP-1 was dominant in both the glandular epithelium and inflammatory infiltration in UC patients. In contrast, in CD subjects the positive expression of MMP-2 and TIMP-1 was in glandular tubes while mainly MMP-7 and TIMP-2 expression was in inflammatory infiltration. Metalloproteinases' expression was associated with the presence of erosions, architectural tissue changes, and inflammatory infiltration in the lamina propria of UC patients. The expression of metalloproteinase inhibitors correlated with the presence of eosinophils and neutrophils in UC and granulomas in CD patients. Our studies indicate that the overexpression of metalloproteinases and weaker expression of their inhibitors may determine the development of IBD. It appears that MMP-2, MMP-7, and MMP-9 may be a potential therapeutic target and the use of their inhibitors may significantly reduce UC progression.
ISSN:1687-6121
1687-630X
DOI:10.1155/2016/2456179